Therapeutic targets for new therapy for corticosteroid refractory asthma. - Wikidata - wikimedia - TriplyDB

Therapeutic targets for new therapy for corticosteroid refractory asthma.

Therapeutic targets for new therapy for corticosteroid refractory asthma.

http://www.wikidata.org/entity/Q37573811

about

Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma Nortriptyline reverses corticosteroid insensitivity by inhibition of phosphoinositide-3-kinase-δ Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition Protein tyrosine phosphatase PTP-RR regulates corticosteroid sensitivity.Passive smoking impairs histone deacetylase-2 in children with severe asthma.Nuclear bioavailability of the glucocorticoid receptor in a pediatric asthma cohort with variable corticosteroid responsiveness.Effects of Aspergillus fumigatus on glucocorticoid receptor and β2-adrenergic receptor expression in a rat model of asthma.Evaluation of different anti-asthmatic drugs on cooling-induced bronchoconstriction

P2860

Q28741172-2A9A3A1D-C05D-4071-BA69-E47DD0C4251F Q34868133-D6DD3CB1-3C6A-4CF8-B1BC-7BECA4D15447 Q36619748-44655965-F157-423E-BB67-19F2CE572971 Q36725196-78FB6C3E-7A7A-40B5-B5DF-FC5F9C73A3D5 Q37553296-20B05F70-7B34-44E4-B5E1-20404F2E72EC Q38844013-D892112B-DC11-47C2-9B10-A69967E71A01 Q40139744-0739C93D-1DC2-4FEB-99BC-71E187AA7FCE Q57112567-64713005-F0A1-4E31-A62E-05F6D7E1DA75

P2860

Therapeutic targets for new therapy for corticosteroid refractory asthma.

http://www.wikidata.org/entity/Q37573811

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic targets for new therapy for corticosteroid refractory asthma.

@en

Therapeutic targets for new therapy for corticosteroid refractory asthma.

@nl

type

label

Therapeutic targets for new therapy for corticosteroid refractory asthma.

@en

Therapeutic targets for new therapy for corticosteroid refractory asthma.

@nl

prefLabel

Therapeutic targets for new therapy for corticosteroid refractory asthma.

@en

Therapeutic targets for new therapy for corticosteroid refractory asthma.

@nl

P1433

Q37573811-D8DB9DAD-6FF1-4D3D-BD31-BB7C2424DDC0

P1476

Q37573811-21984273-C947-47E9-A9D7-8C89CDB8A7E4

P2093

Q37573811-87E85949-A745-4F03-80DD-FFA403580C96

Q37573811-C060C5BC-2A52-42BD-B64D-DC677003DACA

P2860

Q37573811-007FDE59-52FB-4ED3-BA0C-7B82053D6229

Q37573811-027C0216-12ED-4ED3-8BCE-7F5C079F0B90

Q37573811-07DA79DA-B818-4595-BDB9-55311A7236DE

Q37573811-0E0DB051-FBF1-4470-9BF4-4A352CF704D9

Q37573811-0F54089E-4205-417C-BDE9-54B94961F3F4

Q37573811-0F6B6814-9459-47DD-B5B4-B4626D6B2F37

Q37573811-0FA4DF7A-24F9-42C1-A601-0065DEBEB884

Q37573811-145B8AB3-6C2F-4466-8C41-16B1BA48B1F5

Q37573811-1BAF9C96-7199-42DE-82EA-C21B16249A8D

Q37573811-1C191621-BCA9-4520-B6F8-A6D2458DE780

P304

Q37573811-EF973DE3-A53E-49AD-82D5-7CAB2CB22213

P31

Q37573811-0AD2FF92-9EBC-4458-BDD5-5D31860E0EDA

P356

Q37573811-95A4AEFB-C9E0-4E4D-9011-F5B5949FE87C

P407

Q37573811-259C0627-DFC6-429D-97CC-87B61D815963

P433

Q37573811-D54AF20F-4915-413F-B180-61DAC5A2338C

P478

Q37573811-6C3F7A17-4D4B-4C6E-B515-7760807555FF

P577

Q37573811-B93080CE-C964-4AF5-9315-768676F6AF08

P5875

Q37573811-FED311F2-CEFA-4B65-92C6-ECF41295C9FC

P698

Q37573811-2767FCF0-C05E-4370-8AA0-B5E355273DD1

P921

Q37573811-F7FBE892-CF56-40F0-A996-D910AC6AE8D4

P356

14728220903078431

P1433

Expert Opinion on Therapeutic Targets

P1476

Therapeutic targets for new therapy for corticosteroid refractory asthma.

@en

P2093

Kazuhiro Ito

http://www.w3.org/2001/XMLSchema#string

Nicolas Mercado

http://www.w3.org/2001/XMLSchema#string

P2860

Histone acetylation and deacetylation: importance in inflammatory lung diseases

The human glucocorticoid receptor: one gene, multiple proteins and diverse responses

Therapeutic effect of zafirlukast as monotherapy in steroid-naive patients with severe persistent asthma

Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients.

A mutation of the glucocorticoid receptor in primary cortisol resistance.

Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12.

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking.

Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands.

P304

1053-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728220903078431

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26721574

http://www.w3.org/2001/XMLSchema#string

P698

19659447

http://www.w3.org/2001/XMLSchema#string

P921